Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2009 (2009), Article ID 943453, 4 pages
http://dx.doi.org/10.4061/2009/943453
Research Article

Transvenous Closure of Patent Foramen Ovale: Preliminary Results with a New Self-Expanding Nitinol Wire Mesh in a Swine Model

1Department of Cardiology, Clinic of Internal Medicine I, Friedrich Schiller University, 07740 Jena, Germany
2Pediatric Cardiology and Intensive Care Medicine, Georg August University, D 37099 Goettingen, Germany

Received 27 April 2009; Accepted 20 July 2009

Academic Editor: Gaetano Thiene

Copyright © 2009 F. Krizanic et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. T. Hagen, D. G. Scholz, and W. D. Edwards, “Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts,” Mayo Clinic Proceedings, vol. 59, no. 1, pp. 17–20, 1984. View at Google Scholar
  2. P. Lechat, J. L. Mas, G. Lascault et al., “Prevalence of patent foramen ovale in patients with stroke,” The New England Journal of Medicine, vol. 318, no. 18, pp. 1148–1152, 1988. View at Google Scholar
  3. H. Sievert and M. Taaffe, “Patent foramen ovale: the jury is still out,” European Heart Journal, vol. 25, no. 5, pp. 361–362, 2004. View at Publisher · View at Google Scholar · View at PubMed
  4. A. Wahl, M. Kunz, A. Moschovitis et al., “Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism,” Heart, vol. 94, no. 3, pp. 336–341, 2008. View at Publisher · View at Google Scholar · View at PubMed
  5. B. Meier and J. E. Lock, “Contemporary management of patent foramen ovale,” Circulation, vol. 107, no. 1, pp. 5–9, 2003. View at Publisher · View at Google Scholar
  6. S. Windecker, A. Wahl, K. Nedeltchev et al., “Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke,” Journal of the American College of Cardiology, vol. 44, no. 4, pp. 750–758, 2004. View at Publisher · View at Google Scholar · View at PubMed
  7. U. Krumsdorf, S. Ostermayer, K. Billinger et al., “Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients,” Journal of the American College of Cardiology, vol. 43, no. 2, pp. 302–309, 2004. View at Publisher · View at Google Scholar
  8. T. D. King, S. L. Thompson, C. Steiner, and N. L. Mills, “Secundum atrial septal defect: nonoperative closure during cardiac catheterization,” Journal of the American Medical Association, vol. 235, no. 23, pp. 2506–2509, 1976. View at Publisher · View at Google Scholar
  9. H. Hara, R. Virmani, E. Ladich et al., “Patent foramen ovale: standards for a preclinical model of prevalence, structure, and histopathologic comparability to human hearts,” Catheterization and Cardiovascular Interventions, vol. 69, no. 2, pp. 266–273, 2007. View at Publisher · View at Google Scholar · View at PubMed
  10. M. Sigler, S. Handt, M.-C. Seghaye, G. von Bernuth, and R. G. Grabitz, “Evaluation of in vivo biocompatibility of different devices for interventional closure of the patent ductus arteriosus in an animal model,” Heart, vol. 83, no. 5, pp. 570–573, 2000. View at Google Scholar
  11. M. Handke, A. Harloff, M. Olschewski, A. Hetzel, and A. Geibel, “Patent foramen ovale and cryptogenic stroke in older patients,” The New England Journal of Medicine, vol. 357, no. 22, pp. 2262–2268, 2007. View at Publisher · View at Google Scholar · View at PubMed
  12. L. F. Satler, “Should PFO closure devices be used “off label”?” Catheterization and Cardiovascular Interventions, vol. 56, no. 4, p. 527, 2002. View at Google Scholar
  13. A. Mugge, W. G. Daniel, C. Angermann et al., “Atrial septal aneurysm in adult patients: a multicenter study using transthoracic and transesophageal echocardiography,” Circulation, vol. 91, no. 11, pp. 2785–2792, 1995. View at Google Scholar
  14. S. Windecker, A. Wahl, T. Chatterjee et al., “Percutaneous closure of patent foramen ovale in patients with paradoxical embolismml: long-term risk of recurrent thromboembolic events,” Circulation, vol. 101, no. 8, pp. 893–898, 2000. View at Google Scholar
  15. J.-L. Mas, C. Arquizan, C. Lamy et al., “Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both,” The New England Journal of Medicine, vol. 345, no. 24, pp. 1740–1746, 2001. View at Publisher · View at Google Scholar · View at PubMed
  16. D. A. Stone, J. Godard, M. C. Corretti et al., “Patent foramen ovale: association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic events,” American Heart Journal, vol. 131, no. 1, pp. 158–161, 1996. View at Publisher · View at Google Scholar
  17. J.-L. Mas and M. Zuber, “Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack,” American Heart Journal, vol. 130, no. 5, pp. 1083–1088, 1995. View at Publisher · View at Google Scholar
  18. B. Azarbal, J. Tobis, W. Suh, V. Chan, C. Dao, and R. Gaster, “Association of interatrial shunts and migraine headaches: impact of transcatheter closure,” Journal of the American College of Cardiology, vol. 45, no. 4, pp. 489–492, 2005. View at Publisher · View at Google Scholar · View at PubMed
  19. F. E. Willcoxson, J. D. Thomson, and J. L. Gibbs, “Successful treatment of left atrial disk thrombus on an Amplatzer atrial septal defect occluder with abciximab and heparin,” Heart, vol. 90, no. 5, p. e30, 2004. View at Publisher · View at Google Scholar
  20. M. Chessa, M. Carminati, G. Butera et al., “Early and late complications associated with transcatheter occlusion of secundum atrial septal defect,” Journal of the American College of Cardiology, vol. 39, no. 6, pp. 1061–1065, 2002. View at Publisher · View at Google Scholar
  21. P. Acar, Y. Aggoun, and T. Abdel-Massih, “Images in cardiology: thrombus after transcatheter closure of ASD with an Amplatzer septal occluder assessed by three dimensional echocardiographic reconstruction,” Heart, vol. 88, p. 52, 2002. View at Google Scholar
  22. F. Cetta, M. J. Arruda, and L. C. Graham, “Large left atrial thrombus formation despite warfarin therapy after device closure of a patent foramen ovale,” Catheterization and Cardiovascular Interventions, vol. 59, no. 3, pp. 396–398, 2003. View at Publisher · View at Google Scholar · View at PubMed
  23. M. Sigler, T. Paul, and R. G. Grabitz, “Biocompatibility screening in cardiovascular implants,” Zeitschrift für Kardiologie, vol. 94, no. 6, pp. 383–391, 2005. View at Publisher · View at Google Scholar · View at PubMed
  24. M. Sigler and C. Jux, “Biocompatibility of septal defect closure devices,” Heart, vol. 93, no. 4, pp. 444–449, 2007. View at Publisher · View at Google Scholar · View at PubMed
  25. J. Kreutzer, C. A. Ryan, K. Gauvreau, R. Van Praagh, J. M. Anderson, and K. J. Jenkins, “Healing response to the Clamshell device for closure of intracardiac defects in humans,” Catheterization and Cardiovascular Interventions, vol. 54, no. 1, pp. 101–111, 2001. View at Publisher · View at Google Scholar · View at PubMed
  26. F. Krizanic, H. Sievert, D. Pfeiffer, T. Konorza, M. Ferrari, and H.-R. Figulla, “Clinical evaluation of a novel occluder device (Occlutech®) for percutaneous transcatheter closure of patent foramen ovale (PFO),” Clinical Research in Cardiology, vol. 97, no. 12, pp. 872–877, 2008. View at Publisher · View at Google Scholar · View at PubMed